Pfizer Executive Confident in COVID-19 Vaccine Price Increase, $175 per Dose Possible
Pfizer CFO Frank D’Amelio spoke about the outlook for the company’s COVID-19 vaccine. He’s confident that the current price of [...]
How Will Sale and Distribution of Generic Drugs in Washington State Affect Drug Prices?
Surging drug prices have led to widespread frustration across the United States. Washington state’s Senate recently passed drug pricing legislation [...]
How Will Loss of Exclusivity Affect Drug Prices?
Ten drugs are expected to lose their exclusivity this year, including Roche’s Lucentis for macular degeneration. Other companies, such as [...]
Defining Low-Value Care and Improving Healthcare Cost-Effectiveness
A recent report, published in JAMA Health Forum, distinguishes between no-value care and low-value care. The authors ask five questions [...]
National AHIP Conference Provides Information on Drug Pricing and Health Policy Outlook
The national AHIP (America’s Health Insurance Plans) conference took place earlier this week. It provided important information regarding prescription drug [...]
OptumRx Report Critical of $3.6K Topical Gel Price Tag, Highlights Rising Prices of Wound Care Products
Pharmaceutical companies selling wound care products are being criticized for their high prices, especially when generic offerings are sometimes over [...]
Biotech and Pharma Puzzled as Headless FDA Changes Course on Drug Reviews
The FDA has made several recent surprising moves when it comes to drug reviews, leaving many biotech companies puzzled and [...]
Value a Multi-Faceted Element of Curative Therapeutics, Important Consideration for HTAs
A report published in the Journal of Comparative Effectiveness Research explores the possible benefits of curative therapies. The authors compare [...]
Diabetes One of Five Diseases and Disorders Causing Employer Healthcare Costs To Rise, Inequities Reported
According to a report by Health Action Council and UnitedHealth Group, five diseases and disorders are responsible for a growing [...]
Talented Additions to Syneos Health Communications Team Expected to Help Achieve Lofty Goals
Syneos Health Communications has added five experts to their team. These additions include Mark Sudwell as Head of Value, Access, [...]
CMS Reports Record Healthcare Cost of Staggering $3.8 Trillion Pre-COVID-19
A recent report released by CMS notes that healthcare spending rose nearly 5 percent in 2019, equivalent to $3.8 trillion. [...]
ReimbursementCodes Offers Payers a Solution to Rising Drug Prices, Report Details 129% Increase in Price of 9 Prescription Drugs
A new report reveals that the Average Wholesale Price of nine prescription drugs rose by 129% between 2010 and 2016, [...]
PRMA Consulting Declared a Top 10 Outsourcing Consulting Company
Pioneering magazine Pharma Tech Outlook has picked PRMA Consulting as a top consulting company. PRMA Consulting provides unique solutions related [...]
[Book Release] Value-Based Drug Pricing Guide on Flawed $500 Billion Industry Available for Preorder
The Right Price by Peter Neumann, ScD, Joshua Cohen, PhD, and Daniel Ollendorf, PhD, is available for preorder. It will [...]
CMS Outlook Details Major Changes for Payers and Providers, Provides Suggestions to Accelerate Switch to Value-Based Models and Improve Equity
A report from the University of Pennsylvania’s Leonard Davis Institute of Health Economics discusses the coming changes aimed at reducing [...]
New CMS Innovation Appointment Could Affect Medicare Drug Pricing Policy
Elizabeth Fowler has been appointed director of the Center for Medicare and Medicaid Innovation (CMMI). Her previous roles will provide [...]
New CMS Director Could Indicate Shift in Medicare Prescription Drug Pricing Policy
Arielle Woronoff is joining the new administration as director of the CMS Office of Legislation. She previously held worked in [...]
JAMA Article Proposes HTA As Solution for Out-of-Control Prescription Drug Prices; Speculation That Biden Will Look to ICER Model
In a recent article published in JAMA, the authors note that the US spends more per capita for prescription drugs [...]
Sanofi Publishes 2021 Report on Principles in Prescription Drug Pricing, Notes $890 Million in Patient Assistance Programs
Unjustified price increases continue to be a point of contention in the pharma industry. Sanofi has published a report aimed [...]
Novartis and NHS England Agree on Price of Costly SMA Drug; Zolgensma Nearly £1.8 Million per Dose
SMA (spinal muscular atrophy) is characterized by muscle weakness, paralysis, and eventual loss of movement. It is associated with extremely [...]
ICER Reveals Prescription Drug Cost Sharing Policies, Concludes Many Will Dislike Findings
A recent ICER whitepaper discusses a range of policies designed to limit drug prices. It focuses on three main topics [...]
GOP Avoids Drug Cost Questions During Becerra HHS Hearings
Xavier Becerra is Biden’s pick for HHS (Health and Human Services). Earlier this week, he took questions from Republican lawmakers, [...]
Prescription Drugs Only One Piece of High Healthcare Costs–Look to Provider Cost
Dr. Anupam Jena, an associate professor of healthcare policy at Harvard Medical School and doctor at Massachusetts General Hospital, shares [...]
The Case for Prescription Drug Price Transparency: Listen to Patients and Providers
Although recent regulations require healthcare systems to provide pricing information, there is no standardized method to do so. With these [...]
Pricing Experts Offer Insight Into Use of Advanced Analytics, Note 85% of Companies Lack Sufficient Data or Detailed Pricing Information
85% of interviewed companies lack sufficient data, price quality, or price transparency information to be able to properly apply advanced [...]